Blastic Plasmacytoid Dendritic Cell Neoplasia: A Rare Case Report
Open Access
- 7 March 2021
- journal article
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 3 (Supplement), 71-72
- https://doi.org/10.46310/tjim.876554
Abstract
Blastic Plasmacytoid Dendritic Cell Neoplasia (BPDCN) is a rare hematological malignancy whose pathogenesis has not yet been elucidated. Skin, bone marrow, and lymph node involvement can be observed, and it is generally seen in men and old adults. Immunohistochemistry (IHC) features of skin and bone marrow biopsy are essential for diagnosis. There are no standardized treatment options for this malignancy, and the prognosis is particularly poor. Although there are no standardized treatment options for this malignancy, multiple agent chemotherapies such as Hyper-CVAD and CHOP can be used. Bone marrow transplantation may be an option for patients with life expectancy. More case reports are required to understand and manage this extremely rare malignancy. We report the case we encountered in our clinic and selected CVP as the treatment approach.Keywords
This publication has 3 references indexed in Scilit:
- Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted TherapiesTransplantation and Cellular Therapy, 2016
- Blastic plasmacytoid dendritic cell neoplasm: A case report and literature reviewExperimental and Therapeutic Medicine, 2016
- Blastic Plasmacytoid Dendritic Cell Neoplasm: A Clinicopathologic ReviewArchives of Pathology & Laboratory Medicine, 2014